Search for: "KV Pharmaceuticals"
Results 61 - 80
of 92
Sorted by Relevance
|
Sort by Date
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
19 Feb 2012, 4:31 pm
K-V Pharmaceutical Company, C.A. [read post]
27 May 2010, 6:51 am
Within the last two months, I've written about three other companies whose manufacturing practices have been under FDA's scrutiny, including McNeil Pharmaceuticals, Teva Pharmaceuticals and KV Pharmaceutical. [read post]
26 Dec 2011, 12:37 pm
KV Pharmaceuticals Co., 2011 WL 6257466 (E.D. [read post]
5 Apr 2011, 6:00 am
KV Pharmaceutical previously had exclusive permission to sell the drug, but after the company set the drug’s price, the FDA raised concerns about its accessibility to low income-women.President Obama delivered a speech about energy, declaring a national goal of reducing oil imports by a third by 2025, compared to a baseline year of 2008. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent Docs)… [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
2 Mar 2009, 1:47 am
Hat tip to the Courthouse News Service for the KV Pharmaceutical complaint. [read post]
8 Jul 2012, 7:01 pm
Karst – In a rare lawsuit against FDA involving the Orphan Drug Act of 1983, as amended, K-V Pharmaceutical Company (“KV”) and its wholly-owned subsidiary, Ther-Rx Corporation (“Ther-Rx”), filed a Complaint and a Motion for Temporary Restraining Order and Preliminary Injunction in the U.S. [read post]
23 Sep 2009, 4:00 am
(Intellectual Property Watch) Products Coversyl (Perindopril) - Australia: FCA decision a reminder to review issued patent claims in view of newly emerged prior art before filing suit: Apotex Pty Ltd v Les Laboratoires Servier (Patent Baristas) Duac (Clindamycin, Benzoyl) – Perrigo acquires KV Pharmaceutical’s first to file ANDA for generic Duac gel (GenericsWeb) Mircera (Recombinant erythropoietin) – US: CAFC: Section 121 ‘safe… [read post]
6 Aug 2007, 4:37 am
Patent No. 5,001,161, entitled "Pharmaceutical composition comprising metroprolol succinate," and U.S. [read post]
8 Sep 2011, 6:03 am
That’s how KV Pharmaceutical here in St. [read post]
16 May 2012, 12:22 pm
KV Pharmaceutical Co., 2011 WL 6257466, at *6, 8 (E.D. [read post]
20 Oct 2010, 1:20 pm
KV Pharmaceutical Co., 2010 WL 59125 (E.D. [read post]
29 Jul 2010, 6:24 am
Consumers can be hurt by lax manufacturing practices, as KV Pharmaceutical here in St. [read post]
22 Dec 2011, 11:59 am
KV Pharmaceutical Co., 2011 WL 6257466 (E.D. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
